Daan Gene Co. Hits Day Low of CNY 6.56 Amid Price Pressure

Daan Gene Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 5.23% to touch an intraday low of CNY 6.56. This performance stands in contrast to the broader market, as the China Shanghai Composite index only fell by 0.27% on the same day. Over the past week, Daan Gene's stock has decreased by 1.32%, while its monthly performance shows a more positive trend with a gain of 16.09%. However, the company has faced significant challenges over the longer term, with a staggering 44.68% decline over the past three years and a 70.95% drop over the last five years. Financial metrics indicate that Daan Gene has struggled with net sales, which have decreased at an annual rate of 27.73% over the past five years. The company's operating profit has also seen a significant downturn, reflecting a challenging operational environment. With a market capitalization of CNY 8,282 million and a return on equity of -9.28%, Daan Gene continues to navigate a complex financial landscape.